思创医惠
(300078)
| 流通市值：25.69亿 | | | 总市值：26.36亿 |
| 流通股本：8.83亿 | | | 总股本：9.06亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 198,888,851.7 | 1,005,929,309.42 | 801,288,958.5 | 563,307,671.46 |
| 营业收入 | 198,888,851.7 | 1,005,929,309.42 | 801,288,958.5 | 563,307,671.46 |
| 二、营业总成本 | 259,274,307.72 | 1,321,056,125.79 | 893,686,090.35 | 646,974,639.1 |
| 营业成本 | 161,518,898.57 | 794,313,517.55 | 517,240,289.28 | 399,394,929.71 |
| 税金及附加 | 1,002,478.25 | 16,653,098.3 | 10,219,892.53 | 9,203,408.91 |
| 销售费用 | 20,677,802.44 | 136,817,318.33 | 69,335,366.99 | 48,933,190.12 |
| 管理费用 | 27,062,599.15 | 136,553,336.83 | 120,022,720.76 | 69,678,022.77 |
| 研发费用 | 32,012,601.95 | 155,304,149.05 | 119,292,138.15 | 82,117,021.36 |
| 财务费用 | 16,999,927.36 | 81,414,705.73 | 57,575,682.64 | 37,648,066.23 |
| 其中:利息费用 | 17,815,505.02 | 89,619,299.72 | 65,032,771.53 | 43,386,013.39 |
| 其中:利息收入 | -1,165,922.93 | 5,577,931.16 | -3,930,515.72 | -2,331,151.35 |
| 加:公允价值变动收益 | 168,315 | -54,473,501.85 | -1,036,557 | -1,036,557 |
| 加:投资收益 | -2,298,946.65 | -12,090,218.19 | 22,624,005.84 | -218,206.01 |
| 资产处置收益 | -60,157.81 | 242,203.36 | 294,634.24 | 205,905.12 |
| 资产减值损失(新) | 278,200 | -270,512,452.64 | 3,495,275.66 | 6,122,167.76 |
| 信用减值损失(新) | -7,629,879.9 | -85,234,795.26 | -52,173,135.83 | -28,509,689.44 |
| 其他收益 | 1,830,833.99 | 20,347,339.03 | 15,094,269.71 | 11,981,142.18 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -68,097,091.39 | -716,848,241.92 | -104,098,639.23 | -95,122,205.03 |
| 加:营业外收入 | 351,916.22 | 1,408,630.67 | 562,979.41 | 1,197,313.93 |
| 减:营业外支出 | 476,864.51 | 91,924,003.54 | 4,833,670.04 | 458,231.88 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -68,222,039.68 | -807,363,614.79 | -108,369,329.86 | -94,383,122.98 |
| 减:所得税费用 | 354,853.52 | 68,112,332.86 | 3,980,388.84 | 3,970,462.66 |
| 六、净利润 | -68,576,893.2 | -875,475,947.65 | -112,349,718.7 | -98,353,585.64 |
| 持续经营净利润 | -68,576,893.2 | -871,424,582.28 | -112,349,718.7 | -98,353,585.64 |
| 终止经营净利润 | - | -4,051,365.37 | - | - |
| 归属于母公司股东的净利润 | -67,764,977.31 | -874,349,214.78 | -111,637,295.63 | -97,853,581.92 |
| 少数股东损益 | -811,915.89 | -1,126,732.87 | -712,423.07 | -500,003.72 |
| (一)基本每股收益 | -0.07 | -1.06 | -0.14 | -0.12 |
| (二)稀释每股收益 | -0.07 | -1.06 | -0.14 | -0.12 |
| 八、其他综合收益 | -407,982.75 | -11,021,940.25 | 7,938,376.01 | -3,595,871.03 |
| 归属于母公司股东的其他综合收益 | -111,997.56 | -11,167,162.86 | 9,326,635.86 | -3,989,379.88 |
| 九、综合收益总额 | -68,984,875.95 | -886,497,887.9 | -104,411,342.69 | -101,949,456.67 |
| 归属于母公司股东的综合收益总额 | -67,876,974.87 | -885,516,377.64 | -102,310,659.77 | -101,842,961.8 |
| 归属于少数股东的综合收益总额 | -1,107,901.08 | -981,510.26 | -2,100,682.92 | -106,494.87 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 保留意见 | | |